Skip to main content

Want a detailed portfolio tracker?

Kura Oncology (KURA) P/E (2015 - 2026)

Kura Oncology (KURA) P/E from Nov 5, 2015 to Jun 3, 2026. The TTM Kura Oncology (KURA) P/E is -2.57. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Kura Oncology (KURA)

YearP/EChange
2026-2.57-19.55%
2025-3.20-16.94%
2024-3.85-46.32%
2023-7.18+17.38%
2022-6.11-14.21%
2021-7.13-65.04%
2020-20.38+115.13%
2019-9.47+15.10%
2018-8.23-20.68%
2017-10.38+152.49%
2016-4.11-55.96%
2015-9.33N/A

Comparison Kura Oncology (KURA) P/E with competitors

Kura Oncology (KURA) P/E is -2.57.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.07%
NBYStablecoin Development Corp0.10-103.97%
ENLVEnlivex Therapeutics Ltd0.15-105.83%
FGENFibroGen Inc0.24-109.32%
TRAWTraws Pharma Inc0.47-118.36%
FBIOFortress Biotech Inc0.71-127.42%
CHRSCoherus Biosciences Inc0.98-137.99%
ORMPOramed Pharmaceuticals Inc1.47-157.23%
AGENAgenus Inc2.05-179.56%
VIVSVivoSim Labs Inc2.54-198.49%
INVAInnoviva Inc3.19-223.84%
CRMDCorMedix Inc3.65-241.60%
ABEOAbeona Therapeutics Inc4.20-263.32%
VXRTVaxart Inc4.26-265.52%
CVACCureVac N.V.4.45-272.67%
SRPTSarepta Therapeutics Inc4.62-279.60%
GLPGGalapagos NV4.86-288.72%
RIGLRigel Pharmaceuticals4.92-291.07%
ZVRAZevra Therapeutics Inc4.97-293.19%
ABUSArbutus Biopharma Corp5.69-321.14%
CGENCompugen Ltd7.38-386.79%
AUPHAurinia Pharmaceuticals Inc9.25-459.33%
ACADAcadia Pharmaceuticals Inc9.59-472.40%
OMEROmeros Corporation9.88-483.88%
PLXProtalix BioTherapeutics Inc9.91-484.87%
SPROSpero Therapeutics Inc10.73-516.94%
ADMAAdma Biologics Inc11.33-540.09%
SVASinovac Biotech Ltd11.44-544.18%
TBPHTheravance Biopharma Inc11.78-557.41%
HRMYHarmony Biosciences Holdings Inc12.18-573.09%
TGTXTG Therapeutics Inc13.18-611.90%
INCYIncyte Corp13.38-619.77%
SABSSAB Biotherapeutics Inc14.06-646.01%
XOMAXOMA Corp14.95-680.48%
REGNRegeneron Pharmaceuticals Inc14.98-681.84%
PBYIPuma Biotechnology Inc15.05-684.57%
EXELExelixis Inc15.79-713.48%
NAGENiagen Bioscience Inc16.35-735.24%
CPRXCatalyst Pharmaceuticals Inc17.34-773.68%
MDXGMimedx Group Inc17.38-774.87%
ARGXArgen X SE23.07-996.11%
HALOHalozyme Therapeutics Inc23.20-1001.12%
XOMAOXOMA Corp25.34-1084.41%
VRTXVertex Pharmaceuticals Inc25.66-1096.49%
XOMAPXOMA Corp25.67-1097.04%
CTMXCytomX Therapeutics Inc25.70-1098.12%
ASNDAscendis Pharma A/S26.35-1123.61%
RPRXRoyalty Pharma plc - Class A27.50-1167.94%
SLNOSoleno Therapeutics Inc29.02-1226.97%
LGNDLigand Pharmaceuticals Inc - Class B30.19-1272.46%
BMRNBiomarin Pharmaceutical Inc37.51-1556.81%
APLSApellis Pharmaceuticals Inc39.02-1615.61%
KRYSKrystal Biotech Inc39.70-1641.88%
GMABGenmab40.20-1661.53%
ONCBeiGene Ltd67.03-2703.37%
TECHBio-Techne Corp68.59-2764.28%
VCELVericel Corp80.63-3231.69%
PHARPharming Group N.V.87.74-3507.89%
ALNYAlnylam Pharmaceuticals Inc124.93-4952.51%
TLXTelix Pharmaceuticals Ltd139.89-5533.45%
CORTCorcept Therapeutics Inc158.39-6251.95%